PerkinElmer Adds Infectious Disease Testing By Acquiring Oxford Immunotec For $591M
Executive Summary
PerkinElmer’s sales and testing capacity will expand the reach of Oxford Immunotec’s proprietary interferon gamma release tuberculosis assay technology.